These NK cells activated by IL-18 demonstrate accelerated proliferation rates and heightened anti-tumor capabilities, including cytotoxicity, antibody-dependent cytotoxicity, and cytokine production, ultimately exerting anti-tumor effects (34, 35). This evidence concerns the gene IL18 and neoplasm.